1Thompson IM, Pauler DK, Goodman P J, etal. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.. NEngl JMed 2004; 350(22): 2239-2246.
2Nishio R, Furuya Y, Nagakawa O, et al. Metastatic prostate cancer with normal level of serum prostate- specific antigen. Int Urol Nephrol 2003; 35 (2): 189-192.
4Kaplan SA, Lee RK, Chung DE, etM. Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5 a -reductase inhibitors markedly enhances the detection rate of prostate cancer. J Uro12012; 188(3): 757-761.
5Canby-Hagino E, Hemandez J, Brand TC, et M. Prostatecancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL. Urology 2007; 70(4): 748-752.
6Meeks JJ, Loeb S, Helfand BT, etal. Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml. J Uro12009; 181(6): 2515-2518, discussion 2518-2519.
9Pepe P, Panella P, Savoca F, eta1. Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (~<4 ng/mL)and percent free PSA cutoff values of 15 and 20%. Urol Int 2007; 78(4): 308-312.
1KURIYAMA M, WANG M C, PAPSIDERO L D, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay[J]. Cancer Res, 1980, 40..4658-4662.
2SEAMONDS B, YANG N, ANDERSON K, et al. E- valuation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers [J].Urology, 1986, 28:472-479.
3KURIYAMA M, WANG M C, LEE C L, et al. Multi- ple marker evaluation in human prostate cancer with the use of tissue-specific antigens[J].J Natl Cancer Inst, 1982, 68:99-105.
4Pontes J E, Chu T M, Slack N, et al. Serum prostatic antigen measurement in localized prostatic cancer: corre- lation with clinical course[J]. J Urol 1982, 128 : 1216- 1218.
5YAMAMOTO S, TO T, AKIYAMA A, et al. M1 prostate cancer with a serum level of prostate~specific an- tigen less than 10 ng/ml[J]. Int Urol, 2001, 8:374-379.
6LUJAN M, PAEZ A, M1RAVALLES E, et al. Pros- tate cancer detection is also relevant in low prostate~spe- cific antigen ranges[J].Eur Urol, 2004, 45:155-159.
7THOMPSON I M, PAULER D K, GOODMAN P J, et al. Prevalence of prostate cancer among men with a pros- tare-specific antigen Level 4.0 ng per Milliliter[J]. N Engl J Med, 2004, 350:2239-2246.
8NISHIO R, FURUYAY, NAGAKAWA O, et al. Me- tastatic prostate cancer with normal level of serum pros- tare-specific antigen[J].Int Urol Nephrol, 2003, 35: 189 -192.
9DATTA M W, DHIR R, DOBBIN K, et al. Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/ml: results from the co- operative prostate cancer tissue resource [J].J Urol, 2005, 173:1546-1551.
10PELZER A E, VOLGEER H, BEKTIC J, et al. The effect of percentage free prostate-specific antigen(PSA) level on the prostate cancer detection rate in a screening population with low PSA levels[J].BJU Int, 2005, 96 : 955-958.
